Rezolute, Inc. RZLT
Set alert
4.07 USD +0.19 +4.90%
As of Nov 3, 10:07 AM ET
3.90 Day range 4.09
1.07 52-week range 11.46
- YTD
- +72.46%
- 1 year
- -55.27%
- Open
- 3.99
- Prev close
- 3.88
- Mkt cap
- 394.14M
- Vol
- 84.36K
- Avg vol
- 1.50M
- EPS
- -0.75
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 3.90
- High
- 4.09
- Forward P/E
- -3.42
- Beta
- 1.19
- Short ratio
- 3.16
- Inst. own
- 64.24%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 5.12
- 200-d avg
- 4.17
- 1y target
- 13.00
2Y chart
Events in this range
- Nov 5, 2024Rating: Wedbush · — → Outperform
- Nov 8, 2024Rating: HC Wainwright & Co. · Buy → Buy
Signals (102)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Nov 3, 2026 | 37 minutes ago |
| SMA: Bearish | Nov 2, 2026 | 1 day ago |
| MACD: Buy Signal | Oct 28, 2026 | 6 days ago |
| SMA: Bullish | Oct 27, 2026 | 1 week ago |
| SMA: Bearish | Oct 26, 2026 | 1 week ago |
| SMA: Bullish | Oct 22, 2026 | 1 week ago |
| SMA: Bearish | Oct 16, 2026 | 2 weeks ago |
| MACD: Sell Signal | Oct 16, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 14, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 8, 2026 | 3 weeks ago |
| MACD: Buy Signal | Sep 28, 2026 | 1 month ago |
| SMA: Bullish | Sep 21, 2026 | 1 month ago |
| SMA: Bearish | Sep 18, 2026 | 1 month ago |
| SMA: Bullish | Sep 10, 2026 | 1 month ago |
| SMA: Bearish | Sep 9, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 31, 2026 | 2 months ago |
| SMA: Bearish | Aug 28, 2026 | 2 months ago |
| SMA: Bullish | Aug 21, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 21, 2026 | 2 months ago |
| SMA: Bearish | Aug 11, 2026 | 2 months ago |
Newest 20 of 102.
Key statistics
- Market cap
- 257.27M
- Enterprise value
- 192.07M
- Trailing P/E
- 0.00
- Forward P/E
- -3.42
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 1.95
- EPS (TTM)
- -1.27
- Beta
- 1.19
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- -31.00M
- Total cash
- 126.87M
- Total debt
- 2.23M
- Return on equity
- -57.73%
- Shares outstanding
- 57.94M
- Short % of float
- 2.84%
- 50-day average
- 5.12
- 200-day average
- 4.17
Analyst view
Consensus: none
Price target (mean) 13.00 +219.4% upside
Now 4.07
- Target (low)
- 8.00
- Target (mean)
- 13.00
- Target (high)
- 16.00
Ratings (0m) 10 10 buy · 0 hold · 0 sell
- Strong buy3
- Buy7
- Hold0
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate -0.26.
Financials — quick view
RZLT Revenue — quarterly 0
RZLT Net income — quarterly -20.49M
RZLT EPS — quarterly -0.20
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 8, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| Nov 5, 2024 | Wedbush | init | — | Outperform |
| Aug 6, 2024 | Maxim Group | main | Buy | Buy |
| Aug 6, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| Jul 17, 2024 | BTIG | init | — | Buy |
| Jun 4, 2024 | Craig-Hallum | init | — | Buy |
About Rezolute, Inc.
Rezolute, Inc., a late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States. The company's lead product candidate is ersodetug, a human monoclonal antibody that is in Phase 3 clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder. It also developing RZ402, an oral plasma kallikrein inhibitor, which is in Phase 2 clinical trial for the chronic treatment of diabetic macular edema. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was incorporated in 2010 and is headquartered in Redwood City, California.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- rezolutebio.com
News
- Rezolute to Participate in Upcoming Investor Conferences
- Rezolute (NASDAQ:RZLT) Stock Price Crosses Below 200-Day Moving Average – What’s Next?
- Rezolute Completes Enrollment In Open-Label Phase 3 Study Of Ersodetug In Tumor HI; Topline Data Expected In Mid-December 2026
- This NetApp Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
- Lake Street Maintains Buy on Rezolute, Raises Price Target to $12
- Citizens Maintains Market Outperform on Rezolute, Raises Price Target to $15
- This Boyd Gaming Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
- FDA Recommends Meeting for Rezolute Drug for Rare Blood Sugar Disorder Despite Missed Endpoints
- Rezolute Gets FDA Recommendation For Pre-BLA Meeting Ahead Of Ersodetug BLA Submission For Congenital Hyperinsulinism Treatment.
- Why Vicor Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Your note
Sign in to keep a note on RZLT — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ELAM NEVAN C | Chief Executive Officer | Purchase | Feb 25, 2024 | 7,817 |
| EVANS DARON | Chief Financial Officer | Purchase | Dec 17, 2024 | 232,900 |
| HOGENHUIS WLADIMIR | Director | Purchase | Sep 23, 2024 | 41,767 |
| KIM YOUNG-JIN | Director | Purchase | Mar 6, 2024 | 6,058,070 |
| ROBERTS BRIAN KENNETH | Officer | Purchase | Jun 13, 2024 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vivo Capital, LLC | 33.23% | 2,797,704 | 12.42M | Sep 29, 2024 |
| Nantahala Capital Management, LLC | 30.61% | 2,577,121 | 11.44M | Sep 29, 2024 |
| Vanguard Group Inc | 22.95% | 1,932,057 | 8.58M | Sep 29, 2024 |
| Blackstone Inc | 20.73% | 1,744,740 | 7.75M | Sep 29, 2024 |
| Affinity Asset Advisors, Llc | 20.19% | 1,700,000 | 7.55M | Sep 29, 2024 |
| Altium Capital Management, LP | 20.19% | 1,700,000 | 7.55M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Federated Hermes Kaufmann Fund | 45.44% | 3,825,000 | 16.98M | Jul 30, 2024 |
| Federated Hermes Kaufmann Small Cap Fund | 45.29% | 3,812,860 | 16.93M | Jul 30, 2024 |
| Vanguard Total Stock Market Index Fund | 12.85% | 1,081,601 | 4.80M | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 9.06% | 762,525 | 3.39M | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 3.10% | 260,618 | 1.16M | Oct 30, 2024 |
| iShares Micro Cap ETF | 1.22% | 103,090 | 457.72K | Oct 30, 2024 |